Biological Therapies for Multiple Sclerosis (MS):

Biological therapies, such as monoclonal antibodies targeting specific immune cells or proteins involved in MS pathology, have revolutionised the treatment landscape for MS. These medications aim to reduce disease activity, slow progression, and improve symptoms in individuals with relapsing-remitting MS and, in some cases, progressive forms of the disease.